T. Rowe Price Associates’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
23,102
+5,354
| +30% | +$69.8K | ﹤0.01% | 2525 |
|
|
2025
Q1 | $449K | Buy |
17,748
+1,564
| +10% | +$39.6K | ﹤0.01% | 2288 |
|
|
2024
Q4 | $557K | Sell |
16,184
-23,863
| -60% | -$821K | ﹤0.01% | 2237 |
|
|
2024
Q3 | $1.98M | Buy |
40,047
+2,840
| +8% | +$140K | ﹤0.01% | 1641 |
|
|
2024
Q2 | $2.24M | Sell |
37,207
-23,701
| -39% | -$1.43M | ﹤0.01% | 1500 |
|
|
2024
Q1 | $3.14M | Buy |
60,908
+994
| +2% | +$51.3K | ﹤0.01% | 1368 |
|
|
2023
Q4 | $2.42M | Buy |
59,914
+34,003
| +131% | +$1.37M | ﹤0.01% | 1435 |
|
|
2023
Q3 | $724K | Buy |
25,911
+622
| +2% | +$17.4K | ﹤0.01% | 1941 |
|
|
2023
Q2 | $730K | Buy |
+25,289
| New | +$730K | ﹤0.01% | 1959 |
|